SCHEMBL5769816

SCHEMBL5769816

CS(=O)(=O)CC1CC(NC(=O)O)CCC1NC(=O)OCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CPB1 P15086 2/20 0.53
ALDH1A1 P00352 2/20 0.51
GAA P10253 1/20 0.51
TSHR P16473 1/20 0.49
EPHX1 P07099 1/20 0.46
TLR4 O00206 1/20 0.44
TACR1 P25103 2/20 0.43
CTSL P07711 1/20 0.43
CTSB P07858 1/20 0.43
CTSK P43235 1/20 0.43
KDM1A O60341 1/20 0.42
MAOB P27338 1/20 0.42
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
ACHE P22303 2/20 0.41
DPP4 P27487 1/20 0.41
KCNH2 Q12809 1/20 0.41
DPP7 Q9UHL4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3742510 1.00 CPB1 (0.53) CPB1ALDH1A1GAATSHREPHX1
SCHEMBL3742514 1.00 CPB1 (0.53) CPB1ALDH1A1GAATSHREPHX1
SCHEMBL5029620 0.90 ALDH1A1 (0.48) CPB1ALDH1A1GAATSHREPHX1
SCHEMBL5029618 0.90 ALDH1A1 (0.48) CPB1ALDH1A1GAATSHREPHX1
SCHEMBL3731312 0.89 CPB1 (0.50) CPB1ALDH1A1GAATSHREPHX1
SCHEMBL3731309 0.89 CPB1 (0.50) CPB1ALDH1A1GAATSHREPHX1
SCHEMBL5769696 0.89 CPB1 (0.50) CPB1ALDH1A1GAATSHREPHX1
SCHEMBL3738774 0.86 ALDH1A1 (0.55) CPB1ALDH1A1GAATSHREPHX1
SCHEMBL5227953 0.86 ALDH1A1 (0.55) CPB1ALDH1A1GAATSHREPHX1
SCHEMBL3738767 0.86 ALDH1A1 (0.55) CPB1ALDH1A1GAATSHREPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1656345-A1 CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Bristol-Myers Squibb Company (US) 2006-05-17 EP disclosed
WO-2005021500-A1 CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB COMPANY (US) 2005-03-10 WO disclosed